In the BioHarmony Drug Report Database
Insulin lispro
Admelog, Humalog, Liprolog, Liumjev, Lyumjev (insulin lispro) is a protein pharmaceutical. Insulin lispro was first approved as Admelog on 1996-04-30. It is used to treat hyperglycemia, type 1 diabetes mellitus, and type 2 diabetes mellitus in the USA. It has been approved in Europe to treat diabetes mellitus.
Trade Name
|
Humalog, Liprolog, Liumjev, Lyumjev |
|---|---|
Common Name
|
insulin lispro |
ChEMBL ID
|
CHEMBL1201538 |
Indication
|
diabetes mellitus, hyperglycemia, type 1 diabetes mellitus, type 2 diabetes mellitus |
Drug Class
|
Image (chem structure or protein)
